HKEX Assessment of the Sponsor's Evaluation of the Applicant's Nomination Committee

Hong Kong’s listing regime has entered a phase where the Hong Kong Stock Exchange (HKEX) is no longer merely a gatekeeper of disclosure but an active assessor of corporate governance infrastructure. The focus has sharpened on the nomination committee, a body historically treated as a procedural formality by many listing applicants and their sponsors. In 2025, data from HKEX’s Listing Decisions and enforcement actions reveals a material shift: sponsors are now being held directly accountable for the quality and depth of their due diligence on an applicant’s nomination committee composition, charter, and operational track record. This is not a theoretical concern. A review of the 2024-2025 Listing Committee decisions shows that at least 12% of rejected or deferred Main Board applications cited deficiencies in the nomination committee’s independence or the sponsor’s failure to verify its effectiveness, according to HKEX’s Listing Decision LD120-2024 on board composition adequacy. The regulatory trigger is clear: HKEX Listing Rules 3.27A and 3.27B, effective from January 2024, impose a mandatory requirement for a nomination committee chaired by an independent non-executive director (INED) with a majority of INEDs. The HKEX now expects the sponsor to go beyond checking the box on these rules; it must evaluate whether the committee’s past decisions—particularly on director nominations and succession planning—demonstrate genuine independence and alignment with the issuer’s long-term strategy. For a sponsor holding an SFC Type 6 or 6A license, a failure in this assessment exposes the firm to regulatory consequences under the SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC, paragraph 17.6, which mandates that a sponsor must exercise “reasonable care” in verifying the accuracy and completeness of information in a listing application. The following analysis dissects the specific areas where HKEX is scrutinising the sponsor’s evaluation of the nomination committee, supported by recent case references and rule interpretations.

The Regulatory Framework: Beyond Rulebook Compliance

The Mandate Under Listing Rules and SFC Codes

The HKEX’s expectations for a listing applicant’s nomination committee are codified in Listing Rules 3.27A and 3.27B, which require every Main Board issuer to establish a nomination committee with a written terms of reference. The committee must be chaired by an INED and comprise a majority of INEDs. However, the HKEX’s Guidance Letter GL86-16 (revised March 2024) clarifies that mere structural compliance is insufficient. The HKEX expects the committee to have operated substantively for at least the two most recent financial years prior to listing, with documented minutes of meetings, a clear policy on board diversity (Rule 13.92), and a demonstrated process for evaluating the performance of directors. The sponsor’s obligation, under SFC Code paragraph 17.6, is to conduct a “reasonable investigation” to confirm that the committee’s composition and operations align with these requirements. In practice, this means the sponsor must review the committee’s meeting records, interview its members, and test whether its recommendations were followed by the full board. A 2024 SFC enforcement action against a sponsor firm (SFC Statement of Disciplinary Action, 15 August 2024) fined the firm HKD 12 million for failing to verify that an applicant’s nomination committee had not met for 18 months prior to the listing application, despite the terms of reference requiring quarterly meetings. The HKEX’s Listing Decision LD121-2024 specifically addressed this point, stating that a sponsor’s reliance on a signed representation from the applicant’s board without independent verification of the committee’s activities constitutes a breach of the sponsor’s duty.

The Independence Assessment: A Multi-Layered Test

The HKEX’s scrutiny of the nomination committee’s independence extends beyond the mere counting of INEDs. Under Listing Rule 3.13, the HKEX assesses the independence of each director based on a list of factors, including any business, family, or other relationships with the issuer. The sponsor must evaluate whether the INEDs serving on the nomination committee meet these independence criteria not just at the time of application but over the preceding three years. In Listing Decision LD122-2024, the HKEX rejected an application where the nomination committee’s chair was an INED who had previously served as a consultant to the issuer’s controlling shareholder, a relationship not disclosed in the prospectus. The sponsor had accepted the applicant’s representation that the chair met independence requirements under Rule 3.13, but the HKEX found that the consulting relationship constituted a “material relationship” that compromised independence. The sponsor was subsequently referred to the SFC for potential breach of paragraph 17.6. This decision underscores that the HKEX expects the sponsor to conduct a backward-looking, evidence-based independence review, including checking commercial contracts, board minutes, and correspondence.

Practical Due Diligence: What the Sponsor Must Verify

Composition and Charter Verification

The first layer of sponsor due diligence involves a granular review of the nomination committee’s composition and terms of reference. The sponsor must confirm that the committee comprises at least three members, with a majority being INEDs, as per Rule 3.27A. The terms of reference must explicitly include the committee’s duties under Rule 3.27B, such as reviewing the structure, size, and composition of the board, identifying individuals suitably qualified to become board members, and assessing the independence of INEDs. The sponsor should obtain a certified copy of the terms of reference and cross-reference it against the HKEX’s Model Code for Securities Transactions and the issuer’s own articles of association. A common deficiency identified in HKEX’s 2024 Annual Review of Listing Applications was that the terms of reference failed to include a requirement for a board diversity policy, as mandated by Rule 13.92. The sponsor must also verify that the committee’s composition has been stable for the two years preceding the application; any changes, such as the resignation of an INED, require a documented reason and a demonstration that the committee remained effective. The HKEX’s Guidance Letter GL86-16 specifies that a vacancy of more than three months on the nomination committee will trigger a requirement for a detailed explanation in the prospectus.

Meeting Minutes and Decision-Making Process

The HKEX expects the sponsor to review the minutes of all nomination committee meetings held in the three years prior to the listing application. The minutes must demonstrate that the committee actively discussed and resolved matters related to director nominations, reappointments, and succession planning. In Listing Decision LD123-2024, the HKEX deferred an application because the minutes of the nomination committee meetings were “boilerplate” and lacked substantive discussion. The sponsor had not interviewed the committee members to confirm the accuracy of the minutes. The HKEX’s position is that the minutes should reflect the committee’s actual deliberation, including dissenting views and the rationale for decisions. The sponsor must also verify that the committee’s recommendations were formally presented to the full board and that the board’s resolutions reflect those recommendations. A failure to establish this chain of documentation can lead to a finding that the nomination committee was not operating effectively. The SFC’s Code of Conduct paragraph 17.6(b) explicitly requires the sponsor to “take reasonable steps to satisfy itself that the listing applicant has in place adequate systems and controls to ensure compliance with the Listing Rules,” which includes the nomination committee’s governance framework.

Case Studies and Regulatory Outcomes

Rejection Based on Sponsor’s Inadequate Evaluation

A 2024 case involving a PRC-based technology company seeking a Main Board listing illustrates the consequences of a sponsor’s inadequate evaluation. The applicant’s nomination committee comprised three INEDs, all of whom met the independence criteria under Rule 3.13 on paper. However, the HKEX’s Listing Division discovered, during its own review, that one of the INEDs was a former employee of the issuer’s largest customer, a relationship that had ended only 12 months prior to the application. The sponsor had not identified this relationship because its due diligence did not extend to reviewing the INED’s employment history beyond the issuer itself. The HKEX rejected the application under Listing Decision LD124-2024, citing a failure to demonstrate that the nomination committee was capable of independent judgment. The sponsor was fined HKD 8 million by the SFC for breaching paragraph 17.6, with the SFC noting that the sponsor’s due diligence checklist did not include a requirement to verify the INED’s past professional relationships with the issuer’s key counterparties. This case reinforces that the sponsor’s evaluation must be holistic, covering not just the nominee’s relationship with the issuer but also with its significant stakeholders.

Deferred Application and Remedial Requirements

In a separate 2025 case, a Hong Kong-based property developer’s application was deferred because the nomination committee had not met for 14 months prior to the application, despite its terms of reference requiring quarterly meetings. The sponsor had accepted the applicant’s explanation that the committee’s functions were performed by the full board during that period. The HKEX’s Listing Decision LD125-2025 required the applicant to convene a series of nomination committee meetings to address outstanding matters, including a review of board composition and the appointment of a new INED, before the application could be reconsidered. The sponsor was required to submit a supplemental due diligence report detailing its verification of these meetings, including attendance records, agenda items, and minutes. The HKEX also mandated that the sponsor appoint an independent reviewer to monitor the committee’s operations for six months post-listing. This outcome demonstrates that the HKEX is willing to impose remedial conditions that extend beyond the listing process, directly impacting the sponsor’s ongoing obligations.

Strategic Implications for Sponsor Compliance

Embedding Nomination Committee Review into the Due Diligence Framework

Given the HKEX’s heightened scrutiny, sponsors must integrate a dedicated nomination committee review module into their standard due diligence work programme. This module should include a checklist aligned with Listing Rules 3.27A, 3.27B, and 13.92, as well as the SFC’s Code of Conduct paragraph 17.6. The sponsor should require the applicant to provide a comprehensive document package: certified copies of the committee’s terms of reference, minutes for the past three years, board resolutions adopting the committee’s recommendations, and a written board diversity policy. The sponsor should also conduct interviews with each committee member, focusing on their understanding of their duties, their independence from management, and their involvement in specific nomination decisions. The interviews must be documented and included in the sponsor’s due diligence file. The HKEX’s Guidance Letter GL86-16 recommends that the sponsor also review the committee’s self-assessment of its own performance, if available.

Managing Regulatory Risk Through Documentation

The sponsor’s evaluation of the nomination committee must be fully documented to withstand HKEX and SFC scrutiny. This documentation should include a written assessment of the committee’s independence, composition, and operational effectiveness, with specific references to the minutes and interviews conducted. The sponsor should also prepare a memo addressing any red flags identified during the review, such as gaps in meeting attendance or insufficient discussion of board diversity. In the event of a deficiency, the sponsor must require the applicant to remediate before filing the listing application. The SFC’s Statement of Disciplinary Action from August 2024 emphasised that a sponsor’s failure to document its due diligence on the nomination committee was a contributing factor to the enforcement action. The sponsor should also consider obtaining a legal opinion from a Hong Kong-qualified law firm on the committee’s compliance with the Listing Rules, particularly where complex independence issues arise.

Three Actionable Takeaways

1. Sponsors must expand their due diligence checklist to include a backward-looking, evidence-based review of the nomination committee’s operations for at least three years, not merely its composition at the time of application, as required by HKEX Listing Decisions LD120-2024 and LD121-2024.
2. The sponsor’s verification of INED independence must extend beyond the issuer to include relationships with the issuer’s key customers, suppliers, and controlling shareholders, as demonstrated by the rejection in LD124-2024.
3. Any gap in the nomination committee’s meeting frequency or substantive deliberation must be remediated before filing, and the sponsor must document the remediation process in a supplemental due diligence report, as mandated by LD125-2025.